The Health Department on Monday refuted a lawmaker's claim pushing for the use of antiparasitic drug ivermectin against COVID-19, with the solon alleging that the agency could face graft charges for purchasing remdesivir for coronavirus patients.
She said the agency does not purchase this experimental drug as it still does not have a certificate for product registration. "Itong sinasabi na pinoprocure natin ay wala tayong ganung datos o ginawa ang DOH [There is no data or any truth that DOH procured this]. We will not do that because we follow regulatory protocol," she said in a media briefing.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.